Sacral nerve stimulation for bowel control after rectal cancer surgery
Part of Digestive system clinical trials.
This trial tests whether a device that sends gentle electrical pulses to the sacral nerve can improve bowel control in people who have urgency or leakage after rectal cancer surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can give informed consent.
- You had rectal cancer surgery with the remaining bowel reconnected (anastomosis), with or without a temporary ileostomy that has been closed.
- You have more than 6 episodes of urgency or bowel leakage in two weeks, as recorded in a daily diary.
- Your LARS score is above 21, meaning you have moderate to severe bowel dysfunction after rectal surgery.
- You do not have cancer spread (metastasis), are not undergoing chemotherapy, and do not have an ileostomy at the time of the study.
- You do not have a pacemaker, active infection, allergy to implant materials, active inflammatory bowel disease, or had other bowel resections besides the rectal surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a small electrical device placed on the skin behind your ankle can help improve bowel control after surgery to remove rectal cancer. Many patients experience changes in bowel function after this surgery, and this treatment may help restore normal continence.
This trial tests a new, intense form of nerve stimulation through the ankle to help control bowel leakage in people who still have problems after rectal cancer surgery. It may offer a non-surgical option if other treatments have not worked.
This trial tests a special enema program to help people with ongoing bowel problems (called LARS) after rectal cancer surgery. If standard treatments haven't worked, this program might offer a new way to manage symptoms like urgency and leakage.
This trial tests how sacral neuromodulation affects the external anal sphincter in people with fecal incontinence after rectal cancer treatment. It aims to understand if this nerve stimulation can improve muscle function and reduce leakage.
This study helps doctors better understand and treat bowel control problems that can happen after rectal cancer surgery or other rectal treatments. If you've had this surgery or treatment, the study team wants to learn more about your recovery and test new ways to help.
This trial studies whether sacral neuromodulation (a device that sends mild nerve signals) can improve bladder, bowel, and sexual symptoms caused by nerve problems. It is for people whose current bladder treatments have not worked well enough.
Hear when a new Low Anterior Resection Syndrome (LARS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.